Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth

Author： Lam Thomas   Hetherington John   Greenman John   Little Samantha   Maraveyas Anthony  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.46, Iss.8, 2007-01, pp. : 1169-1177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors

By Lu Jianjun   Jackson John   Gleave Martin   Burt Helen  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 997-1005

Springer Publishing Company

Access to resources Recommend Favorite

Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 163-170

Spandidos Publications

Access to resources Recommend Favorite

Metronomic Dosing of Chemotherapy: Applications in Pediatric Oncology

By Stempak Diana   Seely Dugald   Baruchel Sylvain  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 432-443

Informa Healthcare

Access to resources Recommend Favorite

Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2411-2420

Spandidos Publications

Access to resources Recommend Favorite

Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis

By Sher Amna   Wu Shenhong  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite